The leading digital platform solution for lateral flow offering complete connectivity.


TRANSFORM™️ is a secure and compliant digital connectivity platform offering ‘reader - app - cloud - dashboard’ connectivity that is transforming traditional lateral flow assays to digitally connected assays with accessible, shareable data.


Graphic User Interface App

Improving the testing experience for your end user groups in-field, at the point of use.


→ Unique tutorial guiding users through the test process

→ Capturing reader results via secure wireless connection

→ Gathering patient/user-reported data via questionnaires

→ Real-time feedback in-app and in the web dashboard

→ Geotagged, time-stamped results & historical records

→ Instantly shareable data for you and your clients


Cloud Data Management

Securely storing and managing your data for clinical, scientific and commercial gains.


→ Compliant with data privacy & data security legislations

→ Implementation of AI & Machine Learning

→ Scalability and capacity for unlimited number of tests

→ Big data aggregation and management

→ Collects quantitative test results + user-reported data


Data Analytics Dashboards

Visual monitoring of results such as disease outbreaks enabling timely intervention and improved control.


→ Analyse and interpret valuable aggregated data

→ Geotagged, time-stamped results & interactive maps

→ Overlay results with air quality & environmental data

→ Monitor test performance in different locations

→ Instantly share data with relevant stakeholders

→ Own and control your data in our compliant platform

→ Easy to navigate user-friendly interface


platform variants

TRANSFORM™️ is available in three variants customisable to meet your needs, support product intended use and complexity, and comply with strict software regulations.



Designed to support lifestyle assays intended to be used for general testing or research purposes and where the associated risk of harm is low. Suitable for veterinary, food and beverage, and environmental tests.



Designed to support class B and C in vitro medical devices, IVD™️ supports self-testing and near-patient testing assays where there is low to medium risk of harm, such as cholesterol, fertility testing and pregnancy.



Designed to support class C and D in vitro medical devices for self-testing and near-patient testing where there is a high risk of harm. Pro™️ is used with infectious and chronic diseases and monitor disease staging.


Have your own branded version of our technology to offer your clients.


Or learn more by getting in touch here.

platform features

  • Complete wireless connectivity using Bluetooth, Wi-Fi, NFC & Cellular Data

  • Graphic User Interface (GUI) delivered in a native mobile app using best practice UX / UI design

  • Cloud data aggregation & storage

  • Data & results sharing and visualisation in a user-friendly dashboard (tablet, desktop, etc.)

  • Handheld / smartphone reader integration & algorithm interaction

  • Apps enhancing handheld reader capability

Working with us

Bond employs a co-production and innovation approach to ensure clients are involved and engaged in product development and the final product fully meets their needs.

We adopt an Agile development process ensuring high product quality, timely delivery and transparency.

Clients benefit from our extensive regulatory expertise in developing compliant solutions aligned with both data security & data privacy legislation (GDPR, HIPAA) as well as relevant medical device regulations and standards (ISO 13485, IEC 62304, etc.)

We have substantial experience delivering Software as a Medical Device (SaMD) products to the lateral flow market meaning you can trust us to help with your commercial strategy and design a win-win revenue model that works.